4
Changes in Ownership
Perspective Therapeutics, Inc. Filed Acc 0001437749-24-002571
Director bought 135,879 shares at an average $0.58 ($78,474)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Williamson Robert F III Director | 2024-01-26 | Purchase | +12,250 | $0.61 | $7,473 | 87,926 | D: show line 1 in the form |
| Williamson Robert F III Director | 2024-01-26 | Purchase | +14,850 | $0.61 | $9,059 | 102,776 | D: show line 2 in the form |
| Williamson Robert F III Director | 2024-01-26 | Purchase | +8,513 | $0.59 | $5,023 | 111,289 | D: show line 3 in the form |
| Williamson Robert F III Director | 2024-01-26 | Purchase | +25,000 | $0.55 | $13,750 | 136,289 | D: show line 4 in the form |
| Williamson Robert F III Director | 2024-01-26 | Purchase | +50,000 | $0.54 | $27,000 | 186,289 | D: show line 5 in the form |
| Williamson Robert F III Director | 2024-01-29 | Purchase | +4,031 | $0.64 | $2,580 | 190,320 | D: show line 6 in the form |
| Williamson Robert F III Director | 2024-01-29 | Purchase | +21,235 | $0.64 | $13,590 | 211,555 | D: show line 7 in the form |
| Open-market purchases · 135,879 sh · avg $0.58 · $78,474 | |||||||
Loading xslF345X05/rdgdoc.xml…